Hannah Meiselman

I support SB 665 because it strengthens transparency and accountability in PBM operations by requiring written agreements, expanding reporting, increasing fines for violations, and prohibiting steering patients toward PBM-owned pharmacies. These reforms close long-standing loopholes, protect consumers from opaque pricing practices, and ensure fair, auditable oversight across the prescription drug system.